Bipolar II
Resources for Patients and Caregivers
A type of bipolar disorder characterized by depressive and hypomanic episodes.
It involves at least one depressive episode lasting at least two weeks and at least one hypomanic episode lasting at least four days.
Depressive symptoms include sadness or hopelessness. Hypomanic symptoms include a persistently elevated or irritable mood.
Treatment includes counseling and medications, such as mood stabilizers.
Cluster Number:
Wiki Number: 09-Bipolar II
Diagnosis: One or more long sessions of depression, some hypo(lower)mania, but no full manic session
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: May be more chronic and recurring in the depressive phase than Bipolar I.
Progression: May be a high risk of suicide. 25-50% of Bipolar II patients make at least one suicide attempt.
Causes:
Medications: Can be modified by several medications.
Therapies:
Youtube Video: Bipolar 1 or Bipolar 2 Disorder – Which is Worse?
Amazon or Library Book: Bipolar II Disorder Workbook
Click the book to link or order from Amazon.
Support Group: dsballiance.org; 800-326-3632
(Depression and Bipolar Support Alliance)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Pilot study of a ketogenic diet in bipolar disorder: a process evaluationby Benjamin P Rigby on January 21, 2025
CONCLUSION: We provide novel insight into the experiences of people living with bipolar disorder initiating and following a ketogenic diet, as well as those of research clinicians who support the intervention. Future trials may benefit from increased clinical research capacity, better-defined entry and exit routes, additional interpersonal support, and greater understanding of how social and societal factors impact participation.
- Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studiesby Christoph U Correll on January 20, 2025
Objective: To evaluate weight change with a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine by pooling data across clinical studies.
- Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depressionby Chunxiao Dai on January 16, 2025
CONCLUSIONS: This study suggested that lurasidone combination with vortioxetine might have potential benefits to bipolar II depression in the early stage, while disease progression should be monitored closely for the risk of switching to mania.
- Use of Digital Health Interventions for Cancer Prevention Among People Living With Disabilities in the United States: A Scoping Reviewby Chinenye Lynette Ejezie on January 16, 2025
BACKGROUND: The use of digital health strategies for cancer care increased dramatically in the United States over the past 4 years. However, a dearth of knowledge remains about the use of digital health for cancer prevention for some populations with heath disparities. Therefore, the purpose of the present scoping review was to identify digital health interventions for cancer prevention designed for people with disabilities.